Evaluation of chemiluminescence, toluidine blue and histopathology for detection of high risk oral precancerous lesions: A cross-sectional study

BMC Clinical Pathology

Volumn 12, Issue , 2012, Pages

  Ujaoney, Shweta ^a,b   Motwani, Mukta B ^b   Degwekar, Shirish ^b   Wadhwan, Vijay ^b   Zade, Prajakta ^c   Chaudhary, Minal ^b   Hazarey, Vinay ^c   Thakre, Tushar P ^a   Mamtani, Manju ^a,d  

^a Lata Medical Research Foundation   (India)

^b DATTA MEGHE INSTITUTE OF MEDICAL SCIENCES   (India)

^c GOVERNMENT DENTAL COLLEGE AND HOSPITAL   (India)

^d NONE   (United States)

Author keywords

Leukoplakia; Light based methods; Oral cancer; Screening

Indexed keywords

TOLONIUM CHLORIDE;

ADULT; ARTICLE; CANCER DIAGNOSIS; CHEMOLUMINESCENCE; CROSS-SECTIONAL STUDY; FEMALE; GOLD STANDARD; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; LEUKOPLAKIA; MAJOR CLINICAL STUDY; MALE; SENSITIVITY AND SPECIFICITY; TUMOR BIOPSY;

EID: 84857953128     PISSN: None     EISSN: 14726890     Source Type: Journal    
DOI: 10.1186/1472-6890-12-6     Document Type: Article

References (35)

1. The World Cancer Report and the burden of oral cancer. Mignogna MD, Fedele S, Lo Russo L, Eur J Cancer Prev 2004 13 2 139 142 15100581 (Pubitemid 38585334)
2. Oral cancer prevention and control-the approach of the World Health Organization. Petersen PE, Oral Oncol 2009 45 4-5 454 460 10.1016/j. oraloncology.2008.05.023 18804412
3. A cross-sectional study evaluating chemiluminescence and autofluorescence in the detection of clinically innocuous precancerous and cancerous oral lesions. Mehrotra R, Singh M, Thomas S, Nair P, Pandya S, Nigam NS, Shukla P, J Am Dent Assoc 2010 141 2 151 156 20123872
4. Survival from head and neck cancer in Mumbai (Bombay), India. Yeole BB, Sankaranarayanan R, Sunny MSL, Swaminathan R, Parkin DM, Cancer 2000 89 2 437 444 10.1002/1097-0142(20000715)89:2<437::AID-CNCR32>3.0.CO;2-R 10918177 (Pubitemid 30489895)
5. Screening for cervical and oral cancers in India is feasible and effective. Sankaranarayanan R, Natl Med J India 2005 18 6 281 284 16483024 (Pubitemid 43230593)
6. Research on cancer prevention, detection and management in low- and medium-income countries. Sankaranarayanan R, Boffetta P, Ann Oncol 2010 21 10 1935 1943 10.1093/annonc/mdq049 20231304
7. Cervical and oral cancer screening in India. Sankaranarayanan R, Dinshaw K, Nene BM, Ramadas K, Esmy PO, Jayant K, Somanathan T, Shastri S, J Med Screen 2006 13 Suppl 1 35 S38 17227640
8. Early findings from a community-based, cluster-randomized, controlled oral cancer screening trial in Kerala, India. The Trivandrum Oral Cancer Screening Study Group. Sankaranarayanan R, Mathew B, Jacob BJ, Thomas G, Somanathan T, Pisani P, Pandey M, Ramadas K, Najeeb K, Abraham E, Cancer 2000 88 3 664 673 10.1002/(SICI)1097-0142(20000201)88:3<664::AID-CNCR25>3.0.CO;2- V 10649262 (Pubitemid 30056944)
9. Analysis of new diagnostic methods in suspicious lesions of the oral mucosa. Trullenque-Eriksson A, Munoz-Corcuera M, Campo-Trapero J, Cano-Sanchez J, Bascones-Martinez A, Med Oral Patol Oral Cir Bucal 2009 14 5 210 E216 19218907
10. Adjunctive techniques for oral cancer examination and lesion diagnosis: a systematic review of the literature. Patton LL, Epstein JB, Kerr AR, J Am Dent Assoc 2008 139 7 896 905 quiz 993-894 18594075
11. Improving detection of precancerous and cancerous oral lesions. Computer-assisted analysis of the oral brush biopsy. U.S. Collaborative OralCDx Study Group. Sciubba JJ, J Am Dent Assoc 1999 130 10 1445 1457 10570588
12. Validation of the histologic risk model in a new cohort of patients with head and neck squamous cell carcinoma. Brandwein-Gensler M, Smith RV, Wang B, Penner C, Theilken A, Broughel D, Schiff B, Owen RP, Smith J, Sarta C, et al. Am J Surg Pathol 2010 34 5 676 688 20414102
13. Clinical evaluation of chemiluminescent lighting: an adjunct for oral mucosal examinations. Kerr AR, Sirois DA, Epstein JB, J Clin Dent 2006 17 3 59 63 17022366 (Pubitemid 44432882)
14. Chemiluminescence as a diagnostic aid in the detection of oral cancer and potentially malignant epithelial lesions. Ram S, Siar CH, Int J Oral Maxillofac Surg 2005 34 5 521 527 10.1016/j.ijom.2004.10.008 16053872 (Pubitemid 40790349)
15. More about cancer detection. Huff KD, J Am Dent Assoc 2010 141 6 626 628 author reply 628, 630 20516089
16. Detecting oral cancer. Truelove EL, J Am Dent Assoc 2010 141 6 626 author reply 628, 630 20516089
17. Aspects of cell proliferation in oral epithelial dysplastic lesions. Oliver RJ, MacDonald DG, Felix DH, J Oral Pathol Med 2000 29 2 49 55 10.1034/j.1600-0714.2000.290201.x 10718399 (Pubitemid 30104867)
18. Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement. Warnakulasuriya S, Reibel J, Bouquot J, Dabelsteen E, J Oral Pathol Med 2008 37 3 127 133 10.1111/j.1600-0714.2007.00584.x 18251935 (Pubitemid 351178405)
19. Modeling conditional dependence between diagnostic tests: a multiple latent variable model. Dendukuri N, Hadgu A, Wang L, Stat Med 2009 28 3 441 461 10.1002/sim.3470 19067379
20. The use of imperfect diagnostic tests had an impact on prevalence estimation. Ihorst G, Forster J, Petersen G, Werchau H, Rohwedder A, Schumacher M, J Clin Epidemiol 2007 60 9 902 910 10.1016/j.jclinepi.2006.11.016 17689806 (Pubitemid 47198450)
21. Sensitivities and specificities of diagnostic tests and infection prevalence of Schistosoma haematobium estimated from data on adults in villages northwest of Accra, Ghana. Koukounari A, Webster JP, Donnelly CA, Bray BC, Naples J, Bosompem K, Shiff C, Am J Trop Med Hyg 2009 80 3 435 441 19270295
22. Latent variable modeling of diagnostic accuracy. Yang I, Becker MP, Biometrics 1997 53 3 948 958 10.2307/2533555 9290225 (Pubitemid 27391024)
23. Hui and Walter's latent-class reference-free approach may be more useful in assessing agreement than diagnostic performance. Bertrand P, Benichou J, Grenier P, Chastang C, J Clin Epidemiol 2005 58 7 688 700 10.1016/j.jclinepi. 2004.10.021 15939220 (Pubitemid 40797899)
24. On Estimating Diagnostic Accuracy From Studies With Multiple Raters and Partial Gold Standard Evaluation. Albert PS, Dodd LE, J Am Stat Assoc 2008 103 481 61 73 10.1198/016214507000000329 19802353
25. Utility of composite reference standards and latent class analysis in evaluating the clinical accuracy of diagnostic tests for pertussis. Baughman AL, Bisgard KM, Cortese MM, Thompson WW, Sanden GN, Strebel PM, Clin Vaccine Immunol 2008 15 1 106 114 10.1128/CVI.00223-07 17989336 (Pubitemid 351966543)
26. On the estimation of disease prevalence by latent class models for screening studies using two screening tests with categorical disease status verified in test positives only. Chu H, Zhou Y, Cole SR, Ibrahim JG, Stat Med 2010 29 11 1206 1218 20191614
27. Diagnosing diagnostic tests: evaluating the assumptions underlying the estimation of sensitivity and specificity in the absence of a gold standard. Toft N, Jorgensen E, Hojsgaard S, Prev Vet Med 2005 68 1 19 33 10.1016/j.prevetmed.2005.01.006 15795013 (Pubitemid 40413299)
28. Clinical evaluation of an autofluorescence diagnostic device for oral cancer detection: a prospective randomized diagnostic study. Rana M, Zapf A, Kuehle M, Gellrich NC, Eckardt AM, Eur J Cancer Prev 2012 doi: 10.1097/CEJ.0b013e32834fdb6d
29. Evaluation of an autofluorescence based imaging system (VELscope) in the detection of oral potentially malignant disorders and benign keratoses. Awan KH, Morgan PR, Warnakulasuriya S, Oral Oncol 2011 47 4 274 277 10.1016/j. oraloncology.2011.02.001 21396880
30. Diagnosis of oral squamous cell carcinoma and its precursor lesions. Driemel O, Kunkel M, Hullmann M, von Eggeling F, Muller-Richter U, Kosmehl H, Reichert TE, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology: JDDG 2007 5 12 1095 1100 10.1111/j.1610-0387. 2007.06397.x 18042091 (Pubitemid 350239465)
31. Diagnostic clinical aids in oral cancer. Seoane Leston J, Diz Dios P, Oral Oncol 2010 46 6 418 422 10.1016/j.oraloncology.2010.03.006 20371204
32. Analysis of oral lesion biopsies identified and evaluated by visual examination, chemiluminescence and toluidine blue. Epstein JB, Silverman S Jr, Epstein JD, Lonky SA, Bride MA, Oral Oncol 2008 44 6 538 544 10.1016/j.oraloncology.2007.08.011 17996486 (Pubitemid 351681969)
33. The utility of toluidine blue staining and brush cytology as adjuncts in clinical examination of suspicious oral mucosal lesions. Guneri P, Epstein JB, Kaya A, Veral A, Kazandi A, Boyacioglu H, Int J Oral Maxillofac Surg 2011 40 2 155 161 10.1016/j.ijom.2010.10.022 21112183
34. The adjunctive role of toluidine blue in detection of oral premalignant and malignant lesions. Epstein JB, Guneri P, Current opinion in otolaryngology & head and neck surgery 2009 17 2 79 87 10.1097/MOO.0b013e32832771da 22263430
35. The effectiveness of community-based visual screening and utility of adjunctive diagnostic aids in the early detection of oral cancer. Patton LL, Oral Oncol 2003 39 7 708 723 10.1016/S1368-8375(03)00083-6 12907211 (Pubitemid 36930119)